The Algorithm of Us

Chapter 4: The Bonus

The email arrived at 6:47 p.m., flagged with the little red exclamation that Finance reserved for things that required signatures. Claire had been staring at the enrollment spreadsheet for two hours, cross-referencing subject IDs against the demographic columns she'd pulled from the public registry, and she almost archived it without reading.

**RE: FY Compensation Statement — Action Required by Dec 15**

She opened it.

The letter was three paragraphs of boilerplate and one number. Her base salary. Her equity vesting schedule. And then, near the bottom, under *Performance Incentives*:

*Annual discretionary bonus: 40% of base, contingent upon successful FDA 510(k) clearance of the CardioSense platform, target date Q2.*

Claire read it twice. Then a third time, slower, the way she read spec sheets when a number didn't look right.

Forty percent. On top of her base, that was—she did the math without meaning to, the number arriving fully formed, ugly and specific. Enough to cover her mother's assisted living for a year. Enough to stop the monthly transfer that had been quietly draining her savings since March.

She opened her calendar. The launch sign-off was Friday. The FDA submission window closed in six weeks. Clearance target: six months out.

The bonus didn't pay if the device was delayed.

It paid when the device shipped.

Claire sat back in her chair. The office had emptied out around her—the low hum of the HVAC, the blue glow of monitors in the dark bullpen, someone's abandoned mug on the desk across the aisle. She looked at the pink ribbon pin on her lanyard, the enamel catching the light from her screen.

Yolanda Alvarez had been forty-one. Claire knew this because Maria had told her, and because she'd looked it up, and because she kept looking it up, as if the number might change.

She stood, took the elevator down two floors, and walked to Mark's office without knocking.

He was on a call, feet up on the credenza, laughing at something. He waved her in. She waited, hands in her pockets, while he wrapped up—*yeah, yeah, absolutely, we'll get you the numbers, no problem*—and hung up.

"Claire. What's up?" He gestured at the chair. She didn't sit.

"I just got my comp statement."

"Ah." He smiled, easy, and reached for his coffee. "Good news, right? You've earned it. That demo was flawless."

"My bonus is tied to FDA clearance."

"It's tied to launch performance, technically. Standard structure."

"Mark, it's forty percent. Contingent on clearance by Q2."

He set the coffee down. His smile didn't falter, but it tightened at the edges—the way it did when an investor asked about the training data. "It's a standard incentive structure. We want the team aligned with the mission. Everybody on the platform side has the same terms."

"Everybody?"

"Leadership. Product. The clinical liaisons." He spread his hands. "It's not personal, Claire. It's how we retain talent through a long regulatory cycle."

She thought about the enrollment spreadsheet. Seventy-one point four percent male. The three adverse event reports in a binder that should have held twenty. The binder Ethan Cole controlled.

"If the trial is delayed," she said, "I lose the bonus."

"*If* the trial is delayed, we all lose something. That's the point." He leaned back. "Besides, the confirmatory trial is a formality. You and Cole will run it clean, we submit, we ship. Six months, and you're looking at a very good year."

"And if the trial surfaces a problem? If the algorithm is misreading women?"

Mark's expression didn't change, but something behind it closed, like a door settling into a frame. "Claire. We've been through this. The algorithm is validated. The demo proved it. You're chasing a ghost because one advocate got loud in a conference room."

"Her sister died."

"People die of heart attacks. That's what heart attacks do." He picked up a pen, clicked it twice, set it down. "I'm going to give you some advice, and I want you to hear it as advice, not a warning. You're new to the platform side. You've spent your career making things work. Now you're in the room where things get decided, and the deciding is messier than the making. If you go looking for reasons to delay, you'll find them. That's human nature. But the reason we're here is to ship a device that saves lives. The women you're worried about? They're the ones who get hurt if we *don't* ship."

It was a good speech. She could see why he gave it.

"Whose numbers did you use?" she asked.

"Sorry?"

"In the speech. The women who get hurt if we don't ship. Is that from a study, or did you write it yourself?"

Mark's jaw worked once. "Go home, Claire. It's late."

She went back to her desk. She didn't go home.

Instead, she did the thing she'd been avoiding for a week and a half: she opened her personal email on her phone and checked the folder she'd been routing the data-science requests into, the ones she'd sent off-channel, to Priya's personal address, with the subject line *quick q — don't cc the thread.*

Priya had replied at 4:12 p.m. Claire had been in a meeting. She hadn't seen it.

The attachment was a CSV. She opened it on the small screen, pinched to zoom, and read the column headers. *Subject ID. Age. Sex. Presentation. Triage Score. Disposition.*

Two hundred and ten subjects. She scrolled to the *Sex* column and counted in blocks of ten, the way she counted anything when she didn't trust the software to do it for her.

One hundred fifty male. Sixty female.

She'd known the topline number—the 71.4% from the public registry. But the registry was the summary. This was the raw file, the one that fed the algorithm's validation. And there was a column the registry summary didn't have: *Presentation.*

She filtered for female subjects. Sixty rows. She read the presentation codes.

*Chest pain — typical. Chest pain — typical. Dyspnea — atypical. Fatigue, nausea — atypical. Jaw pain — atypical. Chest pain — typical.*

She filtered for the atypical presentations. Thirty-one of the sixty women. More than half. The algorithm had scored them lower—she could see the triage scores dropping down the atypical rows like a staircase—and the dispositions followed. *Discharged. Discharged. Discharged. Follow-up scheduled. Discharged.*

She scrolled to the bottom. There was one more row she hadn't noticed, separated from the others by a blank line, appended after the file's apparent end.

*Subject 211. Age 41. Sex F. Presentation: dyspnea, nausea, fatigue. Triage Score: 2. Disposition: Discharged.*

No subject ID beyond the number. No enrollment date. No site code.

Yolanda had died eight days after discharge. Claire knew the date because Maria had told her, and because she'd written it on the back of a receipt in her coat pocket, and because she'd memorized it the way you memorize a phone number you're afraid of forgetting.

Subject 211 wasn't in the trial. Or she was, but she'd been appended outside the protocol—added late, or moved, or pulled from a file that wasn't supposed to exist. Either way, she was in the data Priya had sent, in the raw file, sitting at the bottom like a footnote no one had read.

Claire stared at it for a long moment. Then she opened a new document, named it *CS_validation_notes_draft_v1*, saved it to her personal cloud drive—not the company server, not the shared folder, not anywhere Mark could see—and began to type.

She documented the enrollment skew first, with the exact figures and the source file name. Then the adverse event count discrepancy: three in the binder Ethan had given her, versus the nineteen she could account for from the site logs she'd pulled from the public registry. Then the presentation codes. Then Subject 211.

She typed for an hour. The office was fully dark now, the cleaning crew's cart rattling somewhere down the hall. Her phone buzzed once—a text from Ethan, *Binder ready for pickup tomorrow 8am, my office*—and she ignored it.

When she finished, she read the document back. It was four pages. It was careful, sourced, and unemotional—the way she'd write a product spec, or a bug report. That was what it was, she realized. A bug report. The device had a defect, and she was documenting it, and the documentation was the only thing standing between the defect and two hundred thousand patients.

She closed the laptop. She reached up and touched the pink ribbon pin on her lanyard, turning it over between her thumb and forefinger. It was warm from her body heat. It had been there for eleven days.

The bonus number sat in her inbox like a weight. Forty percent. A year of her mother's care. Six months away, if she said nothing.

She put on her coat. On the way out, she passed Mark's office—dark now, his chair pushed back, his coffee mug still on the credenza with a ring of dried brown at the bottom.

She pulled the pin off her lanyard and fastened it to her collar, where people could see it.

Then she went home to sleep, because tomorrow was Thursday, and Friday was the sign-off, and she had one more day to decide what she was going to do about Subject 211.

Back to book

Sign in or create an account

Sign in with Google to keep your library and reading progress on every device.

Continue with Google

By continuing you agree to our Terms and Privacy.

Chapter 4: The Bonus · The Algorithm of Us · Lumen Reads